This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Upbound Group, Inc.
Sky Harbour Group Corp. Class A
Karyopharm Therapeutics, Inc.
HeartFlow, Inc.
Faeth Therapeutics, Inc.
Upbound Group, Inc. UPBD | 0.00 | |
Sky Harbour Group Corp. Class A SKYH | 0.00 | |
Karyopharm Therapeutics, Inc. KPTI | 0.00 | |
HeartFlow, Inc. HTFL | 0.00 | |
Faeth Therapeutics, Inc. FTH | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst David Rescott initiated coverage on Heartflow Inc (NASDAQ:HTFL) with an Outperform rating and announced a price target of $34. HeartFlow closed at $25.83 on Thursday. See how other analysts view this stock.
- Roth Capital analyst Tom Hayes initiated coverage on Sky Harbour Group Corp (NYSE:SKYH) with a Buy rating and announced a price target of $14. Sky Harbour shares closed at $10.48 on Thursday. See how other analysts view this stock.
- Raymond James analyst Sean McCutcheon initiated coverage on Faeth Therapeutics, Inc (NASDAQ:FTH) with an Outperform rating and announced a price target of $56. Faeth Therapeutics closed at $28.82 on Thursday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Brett Knoblauch initiated coverage on Duos Technologies Group Inc (NASDAQ:DUOT) with an Overweight rating and announced a price target of $26. Duos Technologies shares closed at $8.14 on Thursday. See how other analysts view this stock.
- Citigroup analyst Renata Cabral initiated coverage on BBB Foods Inc (NYSE:TBBB) with a Buy rating and announced a price target of $49. BBB Foods shares closed at $40.20 on Thursday. See how other analysts view this stock.
Considering buying FTH stock? Here’s what analysts think:
Photo via Shutterstock